| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 1271 |
| 1 | RISPERIDONE | 1051 |
| 2 | ORAL SEMAGLUTIDE | 918 |
| 3 | OLANZAPINE | 823 |
| 4 | QUETIAPINE | 791 |
| 5 | ARIPIPRAZOLE | 760 |
| 6 | PREGABALIN | 710 |
| 7 | PREDNISONE | 663 |
| 8 | GABAPENTIN | 656 |
| 9 | ERGOCALCIFEROL | 654 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFLUOPERAZINE HYDROCHLORIDE | 40 | 0.3175 |
| 1 | PERPHENAZINE | 156 | 0.0747 |
| 2 | SETMELANOTIDE | 17 | 0.0596 |
| 3 | ZIPRASIDONE | 171 | 0.0475 |
| 4 | ZIPRASIDONE HCL | 118 | 0.0444 |
| 5 | DEFLAZACORT | 98 | 0.0380 |
| 6 | HALOPERIDOL DECANOATE | 66 | 0.0379 |
| 7 | VAMOROLONE | 65 | 0.0372 |
| 8 | LOXAPINE | 125 | 0.0313 |
| 9 | AMISULPRIDE | 179 | 0.0292 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 3255 |
| 1 | Atypical Antipsychotic [EPC] | 2390 |
| 2 | Corticosteroid [EPC] | 1582 |
| 3 | Benzodiazepine [EPC] | 1291 |
| 4 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 1271 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1197 |
| 6 | Kinase Inhibitor [EPC] | 684 |
| 7 | Provitamin D2 Compound [EPC] | 654 |
| 8 | Insulin Analog [EPC] | 561 |
| 9 | Proton Pump Inhibitor [EPC] | 550 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 17 | 0.0596 |
| 1 | Adrenocorticotropic Hormone [EPC] | 51 | 0.0570 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 179 | 0.0230 |
| 3 | Provitamin D2 Compound [EPC] | 654 | 0.0220 |
| 4 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 25 | 0.0120 |
| 6 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 13 | 0.0105 |
| 7 | Leptin Analog [EPC] | 13 | 0.0103 |
| 8 | Typical Antipsychotic [EPC] | 198 | 0.0079 |
| 9 | GLP-1 Receptor Agonist [EPC] | 3255 | 0.0073 |